Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN11 | Q06124 | 1/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.31 |
| ▸ | WDR5 | P61964 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13798646 | 0.97 | PTPN11 (0.31) | PTPN11 | |
| SCHEMBL13798648 | 0.88 | PTPN11 (0.37) | PTPN11 | |
| SCHEMBL6123910 | 0.86 | PTPN11 (0.36) | PTPN11 | |
| SCHEMBL6123828 | 0.86 | PTPN11 (0.37) | PTPN11 | |
| SCHEMBL12191838 | 0.85 | PTPN11 (0.35) | PTPN11 | |
| SCHEMBL6125350 | 0.83 | S1PR3 (0.47) | PTPN11S1PR3WDR5 | |
| SCHEMBL6123849 | 0.82 | PTPN11 (0.40) | PTPN11 | |
| SCHEMBL13811608 | 0.81 | S1PR3 (0.44) | PTPN11S1PR3WDR5 | |
| SCHEMBL13868557 | 0.81 | PHLPP2 (0.42) | PTPN11 | |
| SCHEMBL12758902 | 0.81 | PTPN11 (0.32) | PTPN11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8167991-B2 | Trisazo compound, ink composition, recording method, and colored article | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2012-05-01 | — | — | US | disclosed |
| US-7550037-B2 | Ink, ink jet recording method, ink cartridge, recording unit and ink jet recording apparatus | CANON KABUSHIKI KAISHA (JP) | 2009-06-23 | — | — | US | disclosed |
| US-7503967-B2 | Azo compound, ink composition and colored article | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-03-17 | — | — | US | disclosed |
| US-20090062545-A1 | Trisazo Compound, Ink Composition, Recording Method, and Colored Article | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-03-05 | — | — | US | disclosed |
| US-20090011130-A1 | INK, INK JET RECORDING METHOD, INK CARTRIDGE, RECORDING UNIT AND INK JET RECORDING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2009-01-08 | — | — | US | disclosed |
| US-20080193660-A1 | Azo Compound, Ink Composition and Colored Article | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2008-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062545-A1 | Trisazo Compound, Ink Composition, Recording Method, and Colored Article | JAK1, TMT1A, CDK1 | PTPN11 344/4885S1PR3 2237/4885WDR5 1215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.